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Abstract
Background: Malaria and HIV infections during pregnancy can individually or jointly unleash or confound
pregnancy outcomes. Two of the probable outcomes are fetal anemia and cord blood malaria parasitemia. We
determined clinical and demographic factors associated with fetal anemia and cord blood malaria parasitemia in
newborns of HIV-positive women from two districts in Ghana.
Results: We enrolled 1,154 antenatal attendees (443 HIV-positive and 711 HIV-negative) of which 66% were
prospectively followed up at delivery. Maternal malaria parasitemia, and anemia rates among HIV+ participants at
enrolment were 20.3% and 78.7% respectively, and 12.8% and 51.6% among HIV- participants. Multivariate linear
and logistic regression models were used to study associations. Prevalence of fetal anemia (cord hemoglobin
level < 12.5 g/dL) and cord parasitemia (presence of P. falciparum in cord blood at delivery) were 57.3% and 24.4%
respectively. Factors found to be associated with fetal anemia were maternal malaria parasitemia and maternal
anemia. Infant cord hemoglobin status at delivery was positively and significantly associated with maternal
hemoglobin and gestational age whilst female gender of infant was negatively associated with cord hemoglobin
status. Maternal malaria parasitemia status at recruitment and female gender of infant were positively associated
with infant cord malaria parasitemia status.
Conclusions: Our data show that newborns of women infected with HIV and/or malaria are at increased risk of
anemia and also cord blood malaria parasitemia. Prevention of malaria infection during pregnancy may reduce the
incidence of both adverse perinatal outcomes.
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Background
Malaria in pregnancy may be second to only HIV in terms
of mediation of adverse maternal and perinatal outcomes
[1,2]. These infections during pregnancy can individually
or jointly unleash or confound these outcomes. The enor-
mity of the burden of fetal anemia, defined as cord
hemoglobin level < 12.5.0 g/dl, is huge with reportedly very
high prevalence in sub-Saharan Africa. Prevalence of fetal
anemia ranging from 23 – 66% have been observed in
studies in Malawi [3] and Nigeria [4] with one study in
Mozambique documenting up to 93% of newborns [5].
There is a general consensus that HIV-uninfected or
immunocompetent HIV-infected women with relatively
good levels of CD4+ T cells (> 350 cells/μl of blood) can
mount protective immune responses when exposed to
malaria infection, and this can limit malaria and other
infections [6,7].
Malaria infection (at low density) has been shown to in-
duce and sustain the production of the protective cytokine
Interferon gamma (IFN-γ), facilitate protective immune
factors such as Leukocyte Inhibitory Factor (LIF), all of
which, can reduce HIV-1 replication [8]. Women with low
levels of CD4+ T cells (< 350 cells/μl) however, have a
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reduced ability to mount protective immune responses to
either malaria or other infections. HIV-infection severely
impairs both interleukin-12 (IL-12) and cytokine interferon
gamma (IFN-γ) pathways, leading to greater susceptibility
to malaria infection in pregnant women [9]. Women with
suppressed immune system due to HIV- infection are more
likely to develop severe clinical malaria and other oppor-
tunistic illnesses, which can favor overproduction of cyto-
kines such as Tumor Necrosis Factor alpha (TNF-α) [9,10].
This will, in turn, enhance HIV-1 replication, culminating
in adverse outcomes both in the woman and her unborn
baby [10] some of which could result from compromised
materno-fetal substance transfer system.
It has been hypothesized that cord blood may become
infected with malarial parasites through maternal trans-
fusion into fetal circulation either at the time of delivery,
during pregnancy, direct penetration through the chori-
onic villi, and or premature separation of the placenta
[11]. With respect to malaria parasites, other investiga-
tors have argued that the placenta is remarkably capable
of restraining the passage of the Plasmodium species to
the fetus [12], while others [2,9] have suggested an abil-
ity of the fetus to resist infection. This resistance, may
reflect among other things the physical barrier of the
placenta to infected red cells, the passive transfer of ma-
ternal antibodies, and the poor environment afforded by
the fetal red cells for plasmodial replication [2,9-12].
Studies from some African countries have shown the
relationship between cord parasitemia and other adverse
perinatal events but this has been hindered by data pau-
city. Villamor et al. [13] for example examined the risk
of adverse perinatal outcomes in relation to maternal or
umbilical cord Plasmodium falciparum parasitemia among
HIV-infected women from Tanzania and found factors
associated with cord parasitemia included maternal para-
sitemia at the first antenatal visit, and at delivery but not
CD4 cell counts, parity, and zinc supplementation. Related
reports from both malaria-endemic and non-endemic
areas show higher prevalence of cord malaria ranging from
8% to 64.6% [14-17]. The condition in some cases has
been shown to be strongly associated with placental mal-
aria [18], thus increasing drug resistance, virulence of the
parasite, or HIV [19].
Reduced cord blood hemoglobin concentration or fetal
anemia, malaria is thought to play a role through a com-
bination of systemic and local effects [20]. Systemic effects
may be mediated through malaria-induced maternal ane-
mia and local effects through placental malaria infection
[21-23]. While there is currently no agreement as to the
main mechanisms mediating malaria-associated fetal ane-
mia [20], severe or chronic infection and the associated cel-
lular immune responses may result in the consumption of
glucose and oxygen that would have gone to the fetus. His-
topathologic studies of malaria-infected placentae have also
found thickening of the cytotrophoblastic membranes
which may interfere with nutrient transport to the fetus,
subsequently leading to fetal anemia [20,24].
The contributory role of maternal malaria infection in
fetal anemia has been evaluated in a number of studies
with varying results. A Malawian study found a higher
prevalence of fetal anemia to be associated with increas-
ing peripheral and placental parasite densities [3]. Other
studies as reviewed by McElroy et al. [25] have found no
statistically significant connection between evidence of
malaria infection and fetal anemia [25]. A study of pregnant
Turkish women found no significant difference in mean
cord hemoglobin levels of neonates of anemic mothers
compared to those of non-anemic mothers [26]. Relatively
higher prevalence of fetal anemia were observed among ba-
bies born to malaria infected women, HIV-infected women
and anemic women even though the differences were not
statistically significant [27].
Based on these discrepancies in evidence, the predictors
of cord malaria parasitemia, and infant anemia among in-
fants of HIV-positive with malaria are worthy of investi-
gating. We explore maternal anemia at first antenatal visit,
maternal anemia at delivery, maternal malaria infection at
first antenatal visit, and at delivery, maternal malaria infec-
tions both at first antenatal visit and at delivery, maternal
CD4+ T cell count, teen pregnancy as potential predictors
of fetal anemia and umbilical cord parasitemia for malaria.
Methods
The study sites
This study was conducted at three hospitals in Ghana –
the Tema General Hospital in the Tema Municipality,
Greater Accra region, Atua Government Hospital and
St Martin de Porres Hospital both in the Manya Krobo
District, Eastern region.
Study design, population, participants and summary of
field procedures
This prospective study design involved pregnant women
seeking antenatal care services at three public hospitals.
The women who met the study’s inclusion criteria and
consented to enroll in the study were recruited. When
these women returned to deliver at their designated hos-
pitals, follow up data on perinatal outcomes including
fetal hemoglobin concentration and cord blood malaria
parasitemia were measured. Overall 1,154 (443 HIV-
positive and 711 HIV-negative antenatal attendees), 171
with malaria, and 983 without malaria were recruited.
At their first antenatal visit, we collected data on the
background, socio-demographic characteristics, obstetric,
and reproductive history of the study participants. Com-
plete physical and clinical appraisals were carried out by
the experienced nurses/midwives, and 5 ml blood samples
collected by phlebotomists. Seven hundred and sixty-one
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(295 HIV-positive and 466 HIV-negative) of the 1154
women had their follow up data at delivery taken. Details
on the study’s inclusion and exclusion criteria, sample size
determination, sampling and follow up procedures have
been published elsewhere (Laar et al., 2010).
Ethical issues
The research protocol met the guidelines for research in-
volving human subjects of the Noguchi Memorial Institute
for Medical Research (NMIMR). The study protocol was
first reviewed by the Proposal Review Committee of the
School of Public Health, University of Ghana for appropri-
ateness and scientific content. An ethical clearance was
afterwards obtained from the Institutional Review Board
(IRB) of the Noguchi Memorial Institute for Medical Re-
search, University of Ghana, Legon. During field data col-
lection, all eligible prospective women were counseled by
trained nurse counselors, who were informed about the
purpose of the study. Written informed consent, for those
who were literate and witnessed verbal informed consent
for the illiterate were obtained from the study participants.
Subjects were informed about the objectives and methods
of the study. They were also assured of strict confidential-
ity with regards to any information obtained from them.
Laboratory measurements
Blood samples (5 ml) were collected from participating
women at two time points. Venous blood was taken
both at recruitment and at delivery; cord blood was
taken only at delivery into heparinized EDTA vacutainers
for analysis.
Maternal HIV status at recruitment
HIV infection was determined using the Determine® HIV-
1/2 Rapid Test Kit (Abbott Laboratories Diagnostics Div-
ision, IL, USA). It is an immunochromatographic test for
the qualitative detection of antibodies to HIV-1 and HIV-2.
Blood sample is added to the sample pad. As the blood
migrates through the conjugate pad, it reconstitutes and
mixes with the selenium colloid-antigen conjugate. This
mixture continues to migrate through the solid phase to
the immobilized recombinant antigens and synthetic pep-
tides at the patient window site. If antibodies to HIV-1 and
or HIV-2 are present in the blood sample, the antibodies
bind to the antigen-selenium colloid and to the antigen at
the patient window, forming a red line at the patient win-
dow site. If antibodies to HIV-1 and/or HIV-2 are absent,
the antigen-selenium colloid flow past the patient window
and no red line is formed at the patient window site.
Maternal and cord malaria parasitemia
Malaria parasitemia was determined using Rapid Test Kit
(Paracheck Pf, Orchid Biomedical Systems, India) that de-
tects the presence of P. falciparum-specific protein (Pf.
HRP-2) in whole blood specimen up to 14 days after the in-
fection has been cleared. This test also utilizes the principle
of immunochromatography. As the test sample flows
through the membrane assembly of the dipstick after pla-
cing into the clearing buffer tube, the colored anti Pf HRP-
2 antisera-colloidal gold conjugate (monoclonal) complexes
the Pf HRP-2 in the lysed sample. This complex moves
further on the membrane to the test region where it is
immobilized by the anti Pf HRP-2 (monoclonal) antisera
coated on the membrane leading to formation of a pink
colored band which confirms a positive test result. Ab-
sence of this colored band in the test region indicates a
negative test result, with a control band that serves to
validate the test performance.
Maternal and cord blood hemoglobin concentration and
maternal CD4+ count
Maternal venous blood and infant cord blood hemoglo-
bin concentrations were determined using an Automated
Hematologic Analyzer (which measures hemoglobin by
the formation of hemoglobincyanide). In addition the ana-
lyzer also directly measures the cell count for total red
blood cells, white blood cells, and platelets. Maternal CD4+
count was determined using the Becton Dickinson (BD)
FACScount system, which measures absolute CD4 counts
(Immunocytometry Systems, San Jose, CA).
Birth weight and gestational length
A research midwife weighed infants to the nearest 10 g
on a standard seca scale immediately after birth. Gesta-
tional length was determined by last menstrual period of
the study participant.
Data analysis
Statistical analyses were done using SPSS Version 15.0
(SPSS Inc. Chicago, Illinois). Preliminary assessments of
normality of the distributions of relevant continuous out-
come variables were done using normal probability plots.
Appropriate measures of centrality and of dispersion as
well as frequencies were then computed. Proportions of
various outcomes were compared using the the χ2 test.
For comparisons of means of relevant continuous vari-
ables by maternal HIV-infection status, the Independent
T-test was used.
The associations between cord blood malaria parasitemia
status, cord blood hemoglobin concentration and maternal
demographics and clinical outcomes were investigated
using multivariate regression models. The strength of asso-
ciations for binary outcomes was estimated using logistic
regressions and presented as odds ratios (ORs) and their
95% confidence intervals (CI). The confounders and other
covariates used in the multiple regression models were in-
cluded based on a theoretical framework and previous
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studies (refs). The two main outcomes were treated as
follows:
As binary outcomes, cord malaria parasitemia (0 –
malaria parasitemia absent; 1 – malaria parasitemia pres-
ent) fetal anemia (0 – cord blood hemoglobin less than
12.5 g/dL; 1 – cord blood hemoglobin concentration is
greater than 12.5 g/dL). Covariates for these dichotomous
outcomes included maternal anemia at recruitment (per
the three definitions given earlier): anemia, moderately
severe anemia, and severe anemia); maternal anemia at
delivery with the same categories, maternal malaria at
recruitment (0, 1), and maternal malaria at delivery (0, 1).
As a continuous outcome variable, cord blood hemoglobin
concentration were related with birth weight, gestation
length, sex of new born, and maternal parasitemia status
in cord or mother. Two-sided p-values < 0.05 were consid-
ered statistically significant.
Results
The characteristics of study participants (HIV-positive and
HIV-negative women) and their infants are shown in
Table 1 and Table 2. The mean (SD) age of the mothers
was 28 years (Table 1) with a majority of them aged 25
years or older (Table 2). HIV- women were significantly
younger but heavier than their HIV+ counterparts, but
did not differ significantly by body mass index (BMI) –
see Table 1. Related pre-delivery characteristics by mater-
nal HIV-status are presented in Table 2. Such bivariate
analyses revealed significant differences in both maternal
and infant characteristics/outcomes (Table 2).
About a quarter (24.4%) of all babies born to HIV+
women were delivered before term (< 37 weeks gestation)
with mean (SD) gestational age of 37.6 (2.1) weeks and ma-
jority (59%) of the infants were boys. The mean (SD)
hemoglobin level of these infants at birth was 11.7 (2.7) g/dl
and the prevalence of fetal anemia was also high (40%). The
prevalence of cord malaria parasitemia among these group
of HIV-exposed babies was 24.4% and 22.4% of them were
low birth weight. Related statistics for their HIV-unexposed
counterparts are detailed in the same table (Table 1 and
Table 2).
Using multiple regression analysis, the factors associ-
ated with fetal anemia, and also with cord malaria parasit-
emia status are examined (Table 3). Fetal cord hemoglobin
status at delivery was positively and significantly associated
with maternal hemoglobin and gestational age (marginal
significance) whilst female gender of infant was negatively
associated with cord hemoglobin status, such that female
newborns had, on the average 1.05 g/dl Hb lesser than their
male peers. Maternal malaria parasitemia status at recruit-
ment and female gender of infant were positively associated
with fetal cord malaria parasitemia status. A separate sub-
analysis HIV+ mothers and their HIV-exposed newborns
revealed that CD4 count was not significantly associated
with fetal cord hemoglobin or with fetal malaria (p > 0.05
in each case) (data not shown).
Follow up presented in Table 4 respectively identified
gestational age and maternal malaria status as predictors
of fetal anemia and cord blood malaria parasitemia.
Odds of fetal malaria parasitemia for for both HIV status =
negative and HIV status=positive. The multivariable logis-
tic regression revealed “malaria status” was statistically sig-
nificant in both instances.
Discussion
This study presents data that are suggestive that new-
borns of women infected with HIV and/or malaria are at
higher risk of fetal anemia and cord blood malaria para-
sitemia. Fetal cord hemoglobin levels were positively as-
sociated with gestational age and there is a link between
maternal malaria parasitemia and fetal cord anemia in
our study sample. HIV-malaria co-infection is percep-
tibly a strong predictor of adverse perinatal outcomes
and associated morbidity in neonates in the study area.
Table 1 Pre-delivery characteristics of HIV-infected and, HIV-uninfected women, as well as infant outcomes at birth
(n at birth = 295 mother-infant pairs)
N Mean SD Mean difference* 95% CI of the difference
Mother
Age (years) 440 28.5 5.6 −2.1 −2.8 −1.4
Weight (kg) 440 62.5 11.4 3.0 1.4 4.6
Height (cm) 440 159.6 12.2 −1.3 −2.8 0.3
BMI (kg/m2) 440 25.8 16.4 2.9 −0.8 6.6
Hemoglobin level at recruitment (g/dL) 440 9.8 1.7 1.3 1.1 1.4
Infant
Gestational age 295 37.6 2.1 0.7 0.4 1.0
Birth weight 281 2.8 0.5 0.2 0.1 0.3
Fetal Hemoglobin 295 11.7 2.7 −0.9 −1.3 −0.5
*The “means” and “standard deviations” presented in the table are those of HIV+ women; Mean difference = Mean of HIV-negative minus Mean of HIV-positive.
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Prevalence of maternal and fetal anemia among HIV+
women were 78.6% and 40% respectively. The preva-
lence of anemia in pregnancy varies considerably [28,29].
In relations to the findings of McLean [30], in which the
prevalence of anemia among pregnant African women
was estimated to be 55%, our prevalence of 78% could
be attributed to the additional effect of HIV infection.
Several other studies have found high prevalence of fetal
anemia and anemia in pregnancies particularly in sub-
Saharan Africa and this have been attributed partly to
diseases such as malaria and HIV/AIDS [3,29]. Adjusted
odds ratio for the effect of malaria on fetal anemia was
found to be 1.41 (95% CI, 1.05 - 1.90) in this current
study. According to Griffin et al., [31] malaria parasites
tend to have high preference for the placenta for their
replication, evidenced by their proliferation and accumu-
lation in the placenta, thereby infecting red blood cells
of the placenta and reducing fetal hemoglobin levels.
Abrams et al., [32] however found that malaria infection
was associated with low anemia among pregnant mothers
but not fetal hemoglobin. Uneke [27] also found that al-
though prevalence of fetal anemia among women infected
with malaria was higher compared to that of infants born
to malaria uninfected women, the difference was not sta-
tistically significant. The complex and multifactorial influ-
ences on fetal anemia have been suggested as some of the
reasons behind this discrepancy in literature [18].
High prevalence of maternal and infant anemia in this
study can however be attributed largely to the synergistic
effects of HIV and malaria co-infection. In as much as the
study was conducted among HIV positive mothers thereby
reducing the effect of HIV infection on study outcome, the
high proportion of immuno-compromised mothers with
CD4-counts < 350 cells/mm3 (Table 2) cannot be ignored.
In pregnant women, co-infection with HIV and malaria
have been associated with several negative outcomes in
newborns including low birth weight (LBW) attributed
largely to low fetal hemoglobin levels [33-35]. Several
Table 2 Pre-delivery characteristics of study participants and infant outcomes at birth by maternal HIV-status
Mother HIV+ HIV- Chi square p value
Maternal anemia 232 (78.7) 350 (51.6) 0.368 0.832
Maternal malaria 60 (20.3) 91 (12.8) 5.645 0.018
Married or cohabiting 363 (82.5) 476 (66.7) 34.390 <0.001
Up to 9 years of formal education 236 (53.6) 525 (73.8) 49.521 <0.001
Rural residence 333 (75.7) 431 (60.5) 27.937 <0.001
19 years or younger 20 (4.5) 94 (13.2) 37.734 <0.001
20-24 years 85 (19.3) 191 (26.8)
25 years or older 335 (76.1) 427 (60.0)
First trimester 35 (8.0) 73 (10.3) 5.938 0.051
Second trimester 184 (41.8) 329 (46.5)
Third trimester 221 (50.2) 305 (43.1)
Primigravid 129 (29.3) 228 (32.0) 5.509 0.064
Secundigravid 157 (35.7) 207 (29.1)
Multigravid 154 (35.0) 277 (38.9)
Nulliparous 9 (2.9) 273 (38.9) 156.332 <0.001
Primiparous 173 (55.6) 183 (26.1)
Secundiparous 73 (23.5) 138 (19.7)
Multiparous 56 (18.0) 107 (15.3)
CD4-count at recruitment < 350 cells/mm3 133 (45.1) - - -
CD4-count at recruitment < 200 cells/mm3 78 (26.4) - - -
Infant
Anemia (Hb < 12.5 g/dL) 169 (57.3) 319 (71.7) 16.374 <0.001
Female sex, 121 (41.0)) 256 (54.4) 12.924 0.002
Preterm delivery 72 (24.4) 67 (14.5) 11.77 0.003
Low birth weight 1 63 (21.4) 67 (14.7) 7.071 0.029
Cord malaria present 72 (24.4) 52 (11.7) 20.950 <0.001
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studies have also reported positive associations between
HIV infection and higher levels of malaria parasitemia
[13,36,37] where the immuno-compromising effect of HIV
infection, leaves malaria parasites to infect red blood cells.
This causes maternal anemia by decreasing maternal blood
output, and also affecting exchange of materials between
the mother and fetus [20-23]. Such changes may interfere
with the maternal-fetal nutrient and metabolite exchanges,
impairing iron transmission from mother to fetus thereby
resulting in fetal anemia [21,23]. Uneke [27] observed that
the prevalence of fetal anemia was considerably higher
among babies born to HIV-positive mothers compared to
those of HIV-negative mothers. Infant anemia was also
found to be worse in HIV-uninfected infants when born to
HIV-seropositive mothers compared with those born to
HIV-seronegative mothers [38]. Data paucity on the effects
of HIV infection on fetal anemia is a problem, particularly
on the mechanisms although varieties of significant and
positive associations have been found in some sub-Saharan
African countries where HIV is endemic [27,38].
Fetal anemia was found to be significantly associated
positively with maternal hemoglobin levels [0.29 (0.03 –
0.55)]. This indicates that the anemic status of mothers
have some influence on that of their infants at delivery.
These observations are consistent with studies that found
high prevalence of fetal anemia in sub-Saharan African
countries particularly in malaria-endemic regions [3,27,39].
Low maternal hemoglobin at delivery was also found to be
a major factor associated with fetal anemia among southern
Malawi women [3]. Recent studies outside the sub-Saharan
African region have also found positive associations be-
tween maternal and infant hemoglobin and serum ferritin
levels [35,40].
In a study among pregnant women in Bangladesh, Akhter
et al., [35] found that [LOW] maternal hemoglobin due to
iron deficiency (serum ferritin) correlated positively with
cord ferritin (r=0.94; p<0.001) and had significant adverse
effects on fetal outcome, including placental weight and
birth weight. In contrast to the findings of this study, other
studies conducted both within and outside Africa have
found negative or no significant associations between ma-
ternal and infant anemia status [27,32,40,41]. Erdem et al.,
[41] observed from their study in Turkey that cord he-
moglobin and mean corpuscular volumes were not affected
by maternal anemia status. According to them, high serum
erythropoietin levels were associated with low maternal
hemoglobin levels and suggested that maternal anemia ra-
ther induces fetal erythropoiesis. Abrams at al., [32] also
found from their study conducted in Malawi that cord
hemoglobin levels did not correlate to maternal hemoglo-
bin concentration. In a related study, Shao et al., [40] also
Table 4 Maternal pre-delivery and infant predictors of cord hemoglobin concentration and malaria parasitemia of
infants of HIV-negative mothers
95% CI for predicting fetal cord Hb, g/dl
Coefficients, β Lower bound Upper bound P value
Hemoglobin .058 -.080 .330 .232
Sex of child -.043 -.761 .288 .375
Gestational age -.136 -.309 -.054 .005
Malaria infection status .013 -.672 .892 .782
95% CI for predicting fetal cord malaria parasitemia P value
Odds ratio Lower Upper
Malaria Status 3.808 1.916 7.571 <0.001
Sex 1.008 .984 1.033 .497
Maternal anemia 1.035 .566 1.892 .910
Nine of more years of education .863 .418 1.778 .689
Table 3 Maternal pre-delivery and infant predictors of
cord hemoglobin concentration and malaria parasitemia
of infants of HIV-positive mothers
Variable Coefficients, β (95% CI ) for
predicting fetal cord Hb, g/dl
p-value
Fetal cord Hb, g/dl, (n=295) 0.29 (0.03, 0.55) 0.029
Maternal Hb (g/dL) −1.05 (−1.66, -0.44) 0.001
Infant sex (male=0, female=1) 0.21 (−0.01, 0.43) 0.066
Gestational age (wks) −0.29 (−1.12, 0.54) 0.048
Maternal malaria status
Odds ratio (95% CI)
for predicting fetal cord
malaria parasitemia
Fetal cord malaria parasitemia,
(n=295)
Maternal malaria (no=0, yes=1)
Infant sex (male=0, female=1) 0.42 (0.21, 0.84) 0.014
Maternal anemia 1.97 (1.06, 3.66) 0.032
Nine or more years of education 1.07 (0.909, 1.26) 0.067
1.20 (0.68, 2.10) 0.089
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noted that despite widespread maternal iron deficiency
among pregnant Chinese women, iron nutrition seemed to
meet fetal needs except when mothers were very iron defi-
cient (serum ferritin levels below a threshold of 13.6 μg/L
(β = 2.4; P = 0.001).
Gestational age and cord blood hemoglobin concentration
Fetal cord hemoglobin was observed to be positively as-
sociated with gestational age with marginal significance
[0.21 (−0.01, 0.43)]. It is logical to suppose that gestational
age rather has an influence on fetal cord hemoglobin as
development of red blood cells in the infant is progressive
over the gestation period. This result is supported by the
observation that fetal hematocrit increases with gestational
age [42]. This corroborates results from other studies
which indicated that critical changes that ensure develop-
ment of red blood cells in the fetus occur in the last few
weeks of pregnancy (third trimester) and reasonably ex-
plains why preterm babies may be more prone to infant
anemia than full term babies [43]. In utero, fetal and ma-
ternal erythropoiesis occurs independently of each other.
Although the placenta may play a role, the factors respon-
sible for fetal red blood cell production are generally
regarded to be produced by the fetus with erythropoietin;
mainly produced by the liver, as the major growth factor
responsible for fetal and neonatal erythropoiesis [44].
In the last few weeks of pregnancy (about 32 weeks)
matured organs including the kidneys and bone marrow
take over the process of erythropoiesis thereby predis-
posing premature infants whose organs may not be fully
matured to fetal anemia [43].
Sex of newborn versus fetal anemia and cord malaria
Fetal cord hemoglobin status was negatively associated
with female gender of infant [−1.05 (−1.66, -0.44)] (Table 3
and Table 4). This suggests that female infants were at a
greater risk of fetal anemia or anemia in infancy than boys.
There is lack of studies addressing gender differences and
their association with anemia and iron status right at birth
even though some studies have been done in infants in the
early months of life. According to Cassady [45] all infants
experience a reduction in hemoglobin and erythropoietin
production in the first 3 months after birth: the latter due
to transition from a relatively hypoxic state in utero to a
relatively hyperoxic state with increased tissue oxygenation.
Considering that both hemoglobin and erythropoietin are
affected, the findings of studies aimed at determining gen-
der associations with anemia among full term infants par-
ticularly in the early months can be used to discuss the
observations of this study since they may reflect the iron
stores [46]. There is a growing body of evidence indicating
that boys are at greater risk of anemia in infancy than girls
and these are in contrast to the findings of this study [46].
In a recent study by Yang et al., [47] they found that
even though iron deficiency anemia is uncommon among
fully breastfed infants with a birth weight > 2500 g, male
infants stood a higher risk of iron deficiency and iron defi-
ciency anemia than female infants. Relatively high erythro-
poietic activity in boys during fetal life, smaller iron stores
in boys despite their higher birth weight, and the possibil-
ity of boys experiencing higher intestinal losses than girls
have been put forward as some of the likely explanations
for the observed high risk of iron deficiency anemia in
boys than girls during infancy [46]. Nevertheless, further
studies are required in this field considering that fetal
anemia and anemia of infancy are influenced by multiple
factors, and in this study, HIV-infection and malaria, and
genetics may play major and minor roles in complicating
the association between gender and anemia at birth, and
during the early years of infancy. Knowledge in this area
may also be useful in formulating strategies and interven-
tions aimed at protecting infants from anemia as early as
at birth. Infant cord malaria on the other hand was ob-
served to be positively associated with female gender [1.97
(1.06, 3.66)] (Table 3).
Study strengths and limitations
This study is one of the few in Ghana that have attempted
to evaluate the association between HIV on newborn health
indicators, taking into account the effect of malaria. Of
1,154 pregnant women who were recruited into the study,
about 30% were lost to follow-up (LTFU) before delivery. It
is, however, worth noting that in terms of age distribution,
gestation length at first antenatal visit, occupation, and
socio-economic stratification, those women on whom fol-
low up data were available did not differ significantly from
those who were lost to follow-up. Also speculating that the
baseline clinical outcomes of this group of women on
whom data at delivery were available might differ from
those who did not come back to deliver at the study hospi-
tals a similar comparison was made. This analysis again
showed that, with the exception of severe anemia at recruit-
ment, the two groups of study participants were compar-
able (data not shown). On this premise, we proceed to
discuss the study findings with confidence that the women
on whom the main analysis were based, to a large extent
represent the women enrolled into the study.
We, however, acknowledge though that, if an intention
to treat analysis had been done, possibly different con-
clusions would have been made. Nevertheless, this ap-
proach, which works, on the assumption that none of
those lost to follow-up suffered the adverse outcomes of
interest can open the door to a misleading presentation
of study results. It is also worthy of note that, the other
alternative strategies available in dealing with this problem
by imputing outcomes to those lost to follow-up, in gen-
eral, all make unverifiable assumptions that may introduce
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bias in the estimates of treatment effect. We also acknow-
ledge that several variables including timing of cord clamp-
ing could affect the fetal hemoglobin levels. Time of cord
clamping was not documented in our study.
Conclusions
Our data show that newborns of women infected with HIV,
and/or malaria are at increased risk of fetal anemia and also
cord blood parasitemia. Fetal cord hemoglobin levels were
positively and significantly associated with gestational age
and with maternal anemia. This may be uncovering an in-
fluence of maternal anemia and the anemic status of infants
at delivery. The high level of maternal and infant anemia
observed in this study could be attributable to the synergis-
tic effect of HIV and malaria co-infection. Prevention of
malaria infection during pregnancy may reduce the inci-
dence of these adverse perinatal outcomes among HIV-
positive women.
Recommendations
In the settings where both malaria and HIV are co-
endemic, routine screening of pregnant women for both
malaria and HIV at first antenatal visits and intensification
of the education of women at antenatal clinics on adverse
perinatal outcomes attributable to malaria in pregnancy
may be useful remedying actions. Also, deployment of the
various means of preventing malaria, and anemia such as
the use of insecticide treated nets and the use of intermit-
tent preventive treatment (IPT) could equip women with
self-protection tools. Finally, the promotion and encour-
agement of diets rich in iron and folic acid may reduce the
incidence of anemia among this group of women and ul-
timately among newborns.
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